AbbVie Inc's Story
Factors of Production
Its symbol is ABBV and NYSE is the stock exchange it trades under. It has a high of $70.76 and a low of $45.50. Right now it is trading for $58.46. AbbVie Inc pays dividends quarterly. Its last one was $0.49 on 2/13/15. As of now, AbbVie Inc has never had a stock split. It has a
total of 288, 737 shares available for trade. Maxx Chatsko thinks AbbVie Inc is a good investment because it has risen 20% since it hit the market earlier this year, and it pays a heavy dividend. It even managed to beat the S&P 500 by 10%.
AbbVie Inc recently agreed to buy biotech firm Pharmacyclics Inc, the maker of blockbuster blood cancer therapy, Imbruvica. Acquiring Pharmacyclics will give AbbVie access to Imbruvica and boost its oncology drug pipeline. This should make the stock prices rise because there is a better chance the company will become more successful and make more money.
ABBV participated in the Barclays Global Health Care Conference on Thursday, March 12, 2015. Richard A. Gonzalez participated in a question and answer session at 8:30 a.m. I don't think that this will affect the cost prices that much, but they could possibly rise a little bit as their popularity increases.